ACE inhibitors and survival of hemodialysis patients

This publication has 34 references indexed in Scilit:

• Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
  New England Journal of Medicine, 2000
• Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study
  The Lancet, 1999
• Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease
  American Journal of Kidney Diseases, 1998
• Influence of Interdialytic Weight Gain on Blood Pressure in Hemodialysis Patients
  Blood Purification, 1994
• Hyperparathyroidism, platelet intracellular free calcium and hypertension in chronic renal failure
  Kidney International, 1993
• Sympathetic Overactivity in Patients with Chronic Renal Failure
  New England Journal of Medicine, 1992
• Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
  The Lancet, 1992
• Body Fluid Spaces and Blood Pressure in Hemodialysis Patients During Amelioration of Anemia With Erythropoietin
  American Journal of Kidney Diseases, 1990
• Endothelin-3 concentrations in human plasma: The increased concentrations in patients undergoing haemodialysis
  Biochemical and Biophysical Research Communications, 1990
• Hypertension in chronic renal failure: An abnormal relation between sodium and the renin-angiotensin system
  The American Journal of Medicine, 1973